Normark S, Lindquist S, Lindberg F
Scand J Infect Dis Suppl. 1986;49:38-45.
Most enterobacterial species carry a chromosomal ampC beta-lactamase gene. In Escherichia coli and Shigella, expression from ampC is non-inducible and the beta-lactamase is synthesized at low levels. Mutations leading to increased beta-lactamase synthesis occur rather infrequently, making resistance to modern cephalosporins a rare event in these species. In other enterobacteria and Pseudomonas, ampC beta-lactamase synthesis is induced by beta-lactams. In Enterobacter cloacae, Citrobacter freundii and probably also in other species with inducible beta-lactamase expression, ampC is regulated by at least two genes, ampR and ampD. Mutations affecting ampR abolish beta-lactamase inducibility, and mutants devoid of ampR, produce ampC beta-lactamase at low constitutive levels. Mutations in ampD lead to constitutive overproduction of inducible beta-lactamase if an intact ampR protein is present in the cell. The latter type of mutations occur at a high frequency and result in clinical resistance to several third-generation cephalosporins.
大多数肠杆菌属细菌携带染色体AmpCβ-内酰胺酶基因。在大肠杆菌和志贺氏菌中,AmpC的表达是不可诱导的,β-内酰胺酶以低水平合成。导致β-内酰胺酶合成增加的突变很少发生,使得这些菌种对现代头孢菌素产生耐药性成为罕见事件。在其他肠杆菌和假单胞菌中,AmpCβ-内酰胺酶的合成由β-内酰胺诱导。在阴沟肠杆菌、弗氏柠檬酸杆菌以及可能还有其他具有可诱导β-内酰胺酶表达的菌种中,AmpC至少受两个基因ampR和ampD调控。影响ampR的突变会消除β-内酰胺酶的可诱导性,而缺乏ampR的突变体则以低组成水平产生AmpCβ-内酰胺酶。如果细胞中存在完整的ampR蛋白,ampD中的突变会导致可诱导β-内酰胺酶的组成型过量产生。后一种类型的突变发生频率很高,并导致对几种第三代头孢菌素产生临床耐药性。